Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

NCT00190801 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Neoplasms

Interventions

DRUG: pemetrexed
DRUG: cisplatin

Sponsor

Eli Lilly and Company